Literature DB >> 3276417

Liquid-chromatographic measurement of cyclosporin A and its metabolites in blood, bile, and urine.

U Christians1, K O Zimmer, K Wonigeit, G Maurer, K F Sewing.   

Abstract

Using solid-phase extraction columns and "high-performance" liquid-chromatographic (HPLC) analysis, we could determine cyclosporin A and nine of its metabolites in blood, bile, and urine. To facilitate calculations of concentrations of cyclosporin A and its metabolites from the chromatograms, we used cyclosporin D as internal standard. For the HPLC analysis we used two sequential 250-mm analytical columns filled with reversed-phase octyl (C8) sorbent, eluting with a concave gradient of water, adjusted to pH 3.0 with phosphoric acid, and acetonitrile. Peaks were detected at 205 nm. For characterization of the chromatographic peaks, we isolated, by semi-preparative HPLC, 32 fractions representing peaks potentially related to cyclosporin A metabolites and re-injected them into the HPLC system under the same conditions as authentic cyclosporin A metabolites. Analytical recovery was 70-80%. The inter-assay CV for bile was 7.2%, for urine 12.3%. The method was used for routine monitoring of cyclosporin A and its metabolites.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3276417

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

1.  Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients.

Authors:  Steffen Bauer; Elke Störmer; Andreas Johne; Hagen Krüger; Klemens Budde; Hans-Hellmut Neumayer; Ivar Roots; Ingrid Mai
Journal:  Br J Clin Pharmacol       Date:  2003-02       Impact factor: 4.335

2.  Ciclosporin metabolite pattern in blood and urine of kidney graft patients in relation to liver function.

Authors:  J S Bleck; H J Schlitt; U Christians; R Schottmann; C Thiesemann; S Strohmeyer; K Kohlhaw; K Wonigeit; R Pichlmayr; K F Sewing
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  [Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients].

Authors:  H Sperschneider; C Wagner; A Korn; U Christians
Journal:  Med Klin (Munich)       Date:  1997-10-15

4.  Ciclosporin metabolite pattern in blood and urine of liver graft recipients. II. Influence of cholestasis and rejection.

Authors:  U Christians; K Kohlhaw; J Budniak; J S Bleck; R Schottmann; H J Schlitt; V M Almeida; M Deters; K Wonigeit; R Pichlmayr
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  Ciclosporin metabolite pattern in blood and urine of liver graft recipients. I. Association of ciclosporin metabolites with nephrotoxicity.

Authors:  U Christians; K Kohlhaw; J Budniak; J S Bleck; R Schottmann; H J Schlitt; V M Almeida; M Deters; K Wonigeit; R Pichlmayr
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  Sirolimus/cyclosporine/tacrolimus interactions on bile flow and biliary excretion of immunosuppressants in a subchronic bile fistula rat model.

Authors:  Michael Deters; Til Klabunde; Gabriele Kirchner; Klaus Resch; Volkhard Kaever
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

7.  Everolimus/cyclosporine interactions on bile flow and biliary excretion of bile salts and cholesterol in rats.

Authors:  Michael Deters; Gabriele Kirchner; Therese Koal; Klaus Resch; Volkhard Kaever
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

Review 8.  A review of assay methods for cyclosporin. Clinical implications.

Authors:  K T Kivistö
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

9.  Sports Enterprise Marketing and Financial Risk Management Based on Decision Tree and Data Mining.

Authors:  Yan Zhao
Journal:  J Healthc Eng       Date:  2021-10-15       Impact factor: 2.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.